Zobrazeno 1 - 10
of 398
pro vyhledávání: '"Fadini, Gp"'
Publikováno v:
Diabetes, Metabolic Syndrome and Obesity, Vol Volume 15, Pp 3533-3541 (2022)
Gian Paolo Fadini,1 Cristobal Morales,2 Irene Caballero,2 Beatriz González,2 Nikolaos Tentolouris,3 Agostino Consoli4 1Division of Metabolic Diseases, Department of Medicine, University of Padova, Padua, Italy; 2Hospital Virgen Macarena (Sevilla); H
Externí odkaz:
https://doaj.org/article/def2bc4c266d4f009d45c5f6b94b9463
Autor:
Mannucci F, Vitturi G, Benacchio L, Sbrogiò LG, Bano F, Lapolla A, Piarulli F, Giron MC, Avogaro A, Fadini GP
Publikováno v:
Diabetes, Metabolic Syndrome and Obesity, Vol Volume 15, Pp 3093-3101 (2022)
Francesca Mannucci,1 Giacomo Vitturi,2 Luca Benacchio,3 Luca Gino Sbrogiò,4 Francesca Bano,1 Annunziata Lapolla,5 Francesco Piarulli,5 Maria Cecilia Giron,2 Angelo Avogaro,6 Gian Paolo Fadini6 1Pharmaceutical Unit, Local Health Unit 6, Padua, Italy;
Externí odkaz:
https://doaj.org/article/1d584790bedc46398de95f4e7d6e4d84
Publikováno v:
Diabetes, Metabolic Syndrome and Obesity, Vol Volume 13, Pp 4221-4234 (2020)
Mario Luca Morieri, Angelo Avogaro, Gian Paolo Fadini Department of Medicine, University of Padova, Padova 35128, ItalyCorrespondence: Mario Luca MorieriDepartment of Medicine, University of Padova, Via Giustiniani 2, Padova 35128, ItalyTel +39 049 8
Externí odkaz:
https://doaj.org/article/dc598af776a743eeb3d537f5ebd78e23
Publikováno v:
Diabetes, Metabolic Syndrome and Obesity, Vol Volume 13, Pp 161-174 (2020)
Benedetta Maria Bonora, Angelo Avogaro, Gian Paolo Fadini Department of Medicine, University of Padova, Padova 35128, ItalyCorrespondence: Gian Paolo FadiniDepartment of Medicine, University of Padova, Via Giustiniani 2, Padova 35128, ItalyTel +39 49
Externí odkaz:
https://doaj.org/article/57add5ecf2e84f1399d0d1489b66b187
Publikováno v:
Diabetes, Metabolic Syndrome and Obesity, Vol 2014, Iss default, Pp 107-120 (2014)
Mauro Rigato, Gian Paolo Fadini Department of Medicine, University Hospital of Padova, Padova, Italy Abstract: Type 2 diabetes is characterized by a progressive decline in beta cell function, with consequent worsening of glycemic control. The ideal a
Externí odkaz:
https://doaj.org/article/10a69ac5cf7047d28ad81236f84c9c36
Autor:
MOHAMMED SHAFEEQ AHMED, Mattia Albiero, Samuele Ambrosini, Era Gorica, Gergely Karsai, Caravaggi CM, Masi S, Camici GG, Wenzl F, Calderone V, Madeddu P, Sciarretta S, Matter CM, Spinetti G, Luscher TF, Ruschitzka F, Costantino S, Fadini GP, Paneni F
Therapeutic modulation of blood vessel growth holds promise for the prevention of limb ischemia in diabetic (DM) patients with peripheral artery disease (PAD). Epigenetic changes, namely posttranslational histone modifications, participate in angioge
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2659::60f8fdc8ed76d8e728ab5d588b5e46d4
https://zenodo.org/record/5930674
https://zenodo.org/record/5930674
Autor:
Tezze, C, Romanello, V, Desbats, Ma, Fadini, Gp, Albiero, M, Favaro, G, Ciciliot, S, Soriano, Me, Morbidoni, V, Cerqua, C, Loefler, S, Kern, H, FRANCESCHI, CLAUDIO, SALVIOLI, STEFANO, CONTE, MARIA, Blaauw, B, Zampieri, S, Salviati, L, Scorrano, L, Sandri, M.
Mitochondrial dysfunction occurs during aging, but its impact on tissue senescence is unknown. Here, we find that sedentary but not active humans display an age-related decline in the mitochondrial protein, optic atrophy 1 (OPA1), that is associated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______4094::dc650dc9bc89b99f22b2372b5867a3b3
http://hdl.handle.net/11585/597797
http://hdl.handle.net/11585/597797
Autor:
Fadini, Gp, Zatti, G, Baldi, I, Bottigliengo, D, Consoli, A, Giaccari, A, Sesti, G, Avogaro, A, DARWIN-T2D, Network.
Publikováno v:
Diabetes, Obesity & Metabolism
In randomized controlled trials (RCTs), sodium-glucose co-transporter-2 (SGLT2) inhibitors have been shown to confer glycaemic and extra-glycaemic benefits. The DARWIN-T2D (DApagliflozin Real World evIdeNce in Type 2 Diabetes) study was a multicentre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8da85edd5fa3ffeb14207b57e7536c3f
http://hdl.handle.net/10807/116501
http://hdl.handle.net/10807/116501
Autor:
Fadini, G. P., Zatti, G., Consoli, A., Bonora, E., Sesti, G., Avogaro, Consoli A, A. DARWIN-T2D. Network., Formoso, G, Antenucci, D, Grossi, G, Pucci, A, Sesti, G, Andreozzi, F, Indrieri, L, Capobianco, G, Gatti, A, Bonadonna, R, Zavaroni, I, Dei Cas, A, Felace, G, Li Volsi, P, Buzzetti, R, Leto, G, D'Angelo, F, Morano, S, Giaccari, A, Sorice, G, Orsi, E, Carlo Bossi, A, Querci, F, Duratorre, E, Malagola, C, Franzetti, I, Silvia Morpurgo, P, Boemi, M, Petrelli, M, Aimaretti, G, Karamouzis, I, Cavalot, F, Saglietti, G, Gruden, G, Devangelio, E, Cazzetta, G, Lamacchia, O, Cervone, S, Frittitta, L, Arena, S, Di Benedetto, A, Piro, S, Giordano, C, Rizzo, M, Chianetta, R, Mannina, C, Solini, A, Natali, A, Anichini, R, Dotta, F, Fattor, B, Avogaro, A, Fadini, Gp, Bonora, E, Cigolini, M, Simioni, N, Frison, V, Poli, M, Lapolla, A, Cristiano Chilelli, N, Author information, Vinci C.
Background Randomized controlled trials (RCTs) in the field of diabetes have limitations inherent to the fact that design, setting, and patient characteristics may be poorly transferrable to clinical practice. Thus, evidence from studies using routin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::f7aa263ca27b8ac0678785ddb9d534ad
http://hdl.handle.net/10447/414947
http://hdl.handle.net/10447/414947
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.